End-of-day quote
Other stock markets
|
||
- USD | - |
03-15 | Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from S&P TMI Index | CI |
Chart calendar Vical Incorporated
Upcoming events on Vical Incorporated
Past events on Vical Incorporated
15/02/2024 17:00 | Extraordinary Shareholders Meeting |
27/12/2023 17:00 | Extraordinary Shareholders Meeting - Restructuring Vote |
15/12/2023 17:00 | Extraordinary Shareholders Meeting |
30/11/2023 17:00 | Extraordinary Shareholders Meeting - Restructuring Vote |
11/08/2023 21:01 | Q2 2023 Earnings Release |
10/05/2023 21:01 | Q1 2023 Earnings Release |
30/03/2023 21:01 | Q4 2022 Earnings Release |
10/11/2022 21:30 | Q3 2022 Earnings Call |
10/11/2022 21:05 | Q3 2022 Earnings Release |
11/08/2022 21:30 | Interim 2022 Earnings Call |
11/08/2022 21:05 | Interim 2022 Earnings Release |
11/07/2022 14:00 | William Blair Biotech Focus Conference |
04/07/2022 | Reverse Split: 1 of 45 |
29/06/2022 | Extraordinary Shareholders Meeting |
17/05/2022 17:00 | Annual General Meeting - Adjournment Meeting |
12/05/2022 21:30 | Q1 2022 Earnings Call |
12/05/2022 21:01 | Q1 2022 Earnings Release |
03/05/2022 17:00 | Annual General Meeting |
26/03/2022 15:30 | American Academy of Dermatology Meeting |
15/03/2022 12:30 | FY 2021 Earnings Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 7,92 | 1,82 2,30 -20.78% | 0,40 0,45 -11.16% |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | 0,00 | -21,0 -18,2 -15.57% | -40,2 -43,0 6.5% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -20,9 -18,1 -15.54% | -39,5 -42,5 7.06% |
Net income Million USD | Released Forecast Spread | -23,9 | -20,9 -18,1 -15.54% | -39,5 -42,5 7.06% |
EPS USD | Released Forecast Spread | 0,00 | -38,3 -32,0 -19.72% | -22,1 -24,1 8.41% |
Announcement Date | 18/03/20 | 09/03/21 | 15/03/22 |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,10 0,15 -32.79% | 0,09 0,14 -36.03% | 4,32 3,14 37.62% | 0,49 0,43 13.02% |
EBIT Million USD | Released Forecast Spread | -6,31 -9,12 30.9% | -9,41 -6,84 -37.62% | -1,46 -3,45 57.74% | -6,08 -5,59 -8.73% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,07 -9,07 33.11% | -9,41 -6,81 -38.18% | -1,15 -3,45 66.75% | -6,02 -5,49 -9.55% |
Net income Million USD | Released Forecast Spread | -6,07 -9,07 33.11% | -9,41 -6,81 -38.18% | -1,15 -3,45 66.75% | -6,02 -5,49 -9.55% |
EPS USD | Released Forecast Spread | -2,70 -3,83 29.41% | -3,60 -2,59 -39.13% | -0,45 -1,44 68.68% | -2,07 -1,98 -4.68% |
Announcement Date | 15/03/22 | 12/05/22 | 11/08/22 | 10/11/22 |
Past sector events for Vical Incorporated
- Stock Market
- Equities
- FRTX Stock
- Stock
- Calendar Vical Incorporated